Skip to main content
Premium Trial:

Request an Annual Quote

CareDx: Chris Cournoyer

CareDx has named Chris Cournoyer to its board of directors. Cournoyer previously served as chairperson and CEO for precision medicine company N-of-One, vice president of clinical analytics at Optum, and president and chief operating officer of Picis (before it was acquired by Optum). Cournoyer has also held roles at Harte Hanks, Lotus, and IBM, where she served as vice president of global business transformation, has served on the boards of Stride Rite, GTECH, and BJ's Wholesale group, and has been a director for Emerson Hospital. 

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.